8月19日，泰林生物今日收盘26.25元，上涨7.63%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到297.17倍，创312天以来新低，总市值31.81亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均59.49倍，行业中值40.19倍，泰林生物排 名第118位。 来源：金融界 浙江泰林生物技术股份有限公司的主营业务是生命科学领域微生物检测与污染控制、创新药物研发生 产、过程分析和阻遏防护等产品的研发、生产和推广应用，为生物医药、医疗保健、食品饮料、环境保 护等行业提供具有高质量的产品和解决方案。公司的主要产品是集菌仪、集菌培养器、微生物检验仪、 微孔滤膜、酶底物法大肠菌群检测系统、酶底物智能培养计数系统、全自动两虫检测系统、生物指示 剂、生物指示剂抗力仪、质控菌株、隔离器、无菌传递舱、阻遏隔离器、多功能细胞处理工作站、蜂巢 培养系统（转运车+蜂巢培养箱）、无菌分装工作站、汽化过氧化氢发生器、过氧化氢雾化消毒机、全 自动菌落计数工作站、全自动无菌检查培养系统、细菌侵入测试仪、TOC分析仪、固体燃烧装置、生物 降解测试系统、真空/压力衰减测试仪、顶空氧分析仪、过滤器完整性测试仪、过 ...

证券代码：300813 证券简称：泰林生物 公告编号：2025-059 浙江泰林生物技术股份有限公司 关于部分募集资金专用账户销户完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、募集资金基本情况 三、本次注销的部分募集资金专户情况 公司于 2025 年 4 月 24 日召开第四届董事会第七次会议、第四届监事会第七 次会议，于 2025 年 5 月 19 日召开 2024 年年度股东大会，审议通过了《关于 2021 年向不特定对象发行可转换公司债券募集资金投资项目结项并将节余募集资金 投入新项目及永久补充流动资金的议案》，具体内容详见公司在巨潮资讯网 （http://www.cninfo.com.cn）披露的《关于 2021 年向不特定对象发行可转换 公司债券募集资金投资项目结项并将节余募集资金投入新项目及永久补充流动 资金的公告》（公告编号：2025-030）。 基于前述事项，公司 2021 年向不特定对象发行可转换公司债券募集资金专 户"细胞治疗产业化装备制造基地项目"（专户账号：3301040160019344418） 中存放的募集资金及相 ...

资金流向方面，8月15日主力资金净流出270.93万元，近五个交易日累计净流出1592.86万元。 截至2025年8月15日15时，泰林生物股价报23.74元，较前一交易日下跌0.05元，跌幅0.21%。当日开盘 价为23.72元，最高触及24.14元，最低下探23.64元，成交量为19829手，成交额0.47亿元。 泰林生物主营业务为医疗器械及生命科学领域的技术研发与产品生产，涉及机器人概念、空间站概念等 板块。公司产品主要应用于生物制药、医疗卫生等领域。 消息面上，泰林生物全资子公司浙江泰林新材料有限公司近日取得《不动产权证书》，涉及相关资产确 权。 风险提示：股市有风险，投资需谨慎。 ...

Group 1 - The core point of the article is that Tailin Biological (300813) announced that its wholly-owned subsidiary, Zhejiang Tailin New Materials Co., Ltd., has recently obtained the "Real Estate Property Certificate" [1]

Group 1 - Baiya Co., Ltd. achieved a net profit of 188 million yuan in the first half of 2025, a year-on-year increase of 4.64% [1] - The company reported an operating income of 1.764 billion yuan, up 15.12% year-on-year [1] - Basic earnings per share were 0.44 yuan [1] Group 2 - Leike Defense reported a net loss of 41.67 million yuan in the first half of 2025, compared to a loss of 66.43 million yuan in the same period last year [2] - The company achieved an operating income of 542 million yuan, a year-on-year increase of 9.77% [2] - Basic earnings per share were -0.03 yuan [2] Group 3 - Jinggong Technology achieved a net profit of 113 million yuan in the first half of 2025, a year-on-year increase of 15.55% [3] - The company reported an operating income of 1.061 billion yuan, up 10.31% year-on-year [3] - Basic earnings per share were 0.22 yuan [3] Group 4 - Yuejian Intelligent reported a net profit of 62.63 million yuan in the first half of 2025, a year-on-year increase of 46.99% [4] - The company achieved an operating income of 651 million yuan, up 13.22% year-on-year [4] - Basic earnings per share were 0.2436 yuan [4] Group 5 - Wanwei High-tech achieved a net profit of 256 million yuan in the first half of 2025, a year-on-year increase of 97.47% [6] - The company reported an operating income of 4.061 billion yuan, up 4.90% year-on-year [6] - Basic earnings per share were 0.122 yuan [6] Group 6 - Keli Equipment achieved a net profit of 82.78 million yuan in the first half of 2025, a year-on-year increase of 4.88% [7] - The company reported an operating income of 318 million yuan, up 12.41% year-on-year [7] - Basic earnings per share were 0.87 yuan [7] Group 7 - Jinwo Co., Ltd. achieved a net profit of 25.47 million yuan in the first half of 2025, a year-on-year increase of 94% [8] - The company reported an operating income of 614 million yuan, up 7.96% year-on-year [8] - Basic earnings per share were 0.21 yuan [8] Group 8 - Longyuan Technology achieved a net profit of 28.28 million yuan in the first half of 2025, a year-on-year increase of 135.6% [10] - The company reported an operating income of 362 million yuan, up 1.48% year-on-year [10] - Basic earnings per share were 0.0548 yuan [10] Group 9 - Guangting Information achieved a net profit of 42.92 million yuan in the first half of 2025, turning from loss to profit [13] - The company reported an operating income of 275 million yuan, up 26.88% year-on-year [13] - Basic earnings per share were 0.4633 yuan [13] Group 10 - Changjiang Materials achieved a net profit of 73.38 million yuan in the first half of 2025, a year-on-year increase of 5.03% [15] - The company reported an operating income of 513 million yuan, up 10.43% year-on-year [15] - Basic earnings per share were 0.5019 yuan [15] Group 11 - Yitong Century reported a net loss of 1.77 million yuan in the first half of 2025, compared to a profit of 35.87 million yuan in the same period last year [17] - The company achieved an operating income of 1.22 billion yuan, down 0.54% year-on-year [17] - Basic earnings per share were -0.0020 yuan [17] Group 12 - China Nuclear Construction signed new contracts worth 90.48 billion yuan in July 2025 [19] - The company achieved a cumulative operating income of 58.229 billion yuan [19] Group 13 - Yinlong Co., Ltd. signed a construction labor subcontracting contract worth 108 million yuan [21] - The contract is for the prefabrication of CRTSIII-type track slabs for a railway project [21] Group 14 - Xinan Century plans to apply for a comprehensive credit limit of no more than 50 million yuan from a bank [23] - The limit will be used for various business purposes including working capital loans [23] Group 15 - New Hongtai reported a net profit of 34.27 million yuan in the first half of 2025, a year-on-year decrease of 8.94% [25] - The company achieved an operating income of 308 million yuan, down 2.45% year-on-year [25] - Basic earnings per share were 0.23 yuan [25] Group 16 - Botong Co., Ltd. achieved a net profit of 13.33 million yuan in the first half of 2025, a year-on-year increase of 42.95% [26] - The company reported an operating income of 149 million yuan, up 5.23% year-on-year [26] - Basic earnings per share were 0.2135 yuan [26] Group 17 - Minfeng Special Paper reported a net profit of 15.07 million yuan in the first half of 2025, a year-on-year decrease of 68.88% [28] - The company achieved an operating income of 601 million yuan, down 23.21% year-on-year [28] - Basic earnings per share were 0.043 yuan [28] Group 18 - Changchun Yidong announced that a shareholder plans to reduce their stake by up to 2.97% [29] - The reduction period is from September 8, 2025, to December 5, 2025 [29] Group 19 - Jiukang Bio received an invention patent certificate for a reagent [30] - The patent involves the application of a specific enzyme in diagnostic reagents [30] Group 20 - Xuelang Environment announced the resignation of its general manager due to personal reasons [31] - The chairman will temporarily take over the general manager's responsibilities [31] Group 21 - Tailin Bio's subsidiary obtained a property certificate for industrial land [32] - The land area is 20,500 square meters with a usage period until July 6, 2075 [32] Group 22 - Changgao Electric New's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [33] Group 23 - Tianyoude Wine plans to use up to 147 million yuan of idle funds for cash management [34] Group 24 - Lingxiao Pump Industry used 5.9 million yuan of idle funds to purchase financial products [36] Group 25 - Mengke Pharmaceutical announced that a shareholder plans to reduce their stake by up to 3% [38] Group 26 - Kexiang Co., Ltd. plans to raise no more than 300 million yuan through a simplified procedure [40] Group 27 - Huagong Technology achieved a net profit of 911 million yuan in the first half of 2025, a year-on-year increase of 44.87% [42] - The company reported an operating income of 7.629 billion yuan, up 44.66% year-on-year [42] - Basic earnings per share were 0.91 yuan [42] Group 28 - Shanghai Jianke achieved a net profit of 23.76 million yuan in the first half of 2025, a year-on-year increase of 48.57% [43] - The company reported an operating income of 1.935 billion yuan, up 0.60% year-on-year [43] - Basic earnings per share were 0.06 yuan [43] Group 29 - Darui Electronics achieved a net profit of 132 million yuan in the first half of 2025, a year-on-year increase of 25.32% [44] - The company reported an operating income of 1.405 billion yuan, up 28.04% year-on-year [44] - Basic earnings per share were 1.00 yuan [44] Group 30 - Dongyangguang achieved a net profit of 613 million yuan in the first half of 2025, a year-on-year increase of 170.57% [45] - The company reported an operating income of 7.124 billion yuan, up 18.48% year-on-year [45] - Basic earnings per share were 0.209 yuan [45] Group 31 - Chongqing Beer reported a net profit of 865 million yuan in the first half of 2025, a year-on-year decrease of 4.03% [49] - The company achieved an operating income of 8.839 billion yuan, down 0.24% year-on-year [49] - Basic earnings per share were 1.79 yuan [49] Group 32 - Chongqing Beer announced that its subsidiary plans to increase capital by 600 million yuan [51] Group 33 - Meixin Technology announced that a shareholder plans to reduce their stake by up to 3% [53] Group 34 - Qipai Technology plans to raise no more than 159 million yuan through a private placement [55] Group 35 - Qipai Technology reported a net loss of 586.69 million yuan in the first half of 2025 [57] - The company achieved an operating income of 326 million yuan, up 4.09% year-on-year [57] - Basic earnings per share were -0.55 yuan [57] Group 36 - Huaying Technology reported a net loss of 476 million yuan in the first half of 2025 [59] - The company achieved an operating income of 721 million yuan, down 16.59% year-on-year [59] - Basic earnings per share were -0.1723 yuan [59] Group 37 - Best reported a net profit of 148 million yuan in the first half of 2025, a year-on-year increase of 3.30% [61] - The company achieved an operating income of 716 million yuan, up 2.73% year-on-year [61] - Basic earnings per share were 0.2966 yuan [61] Group 38 - Changliang Technology reported a net loss of 19.11 million yuan in the first half of 2025 [62] - The company achieved an operating income of 664 million yuan, down 5.64% year-on-year [62] - Basic earnings per share were -0.0236 yuan [62] Group 39 - Shunhao Co., Ltd. plans to use up to 35 million yuan of idle funds for entrusted wealth management [64] Group 40 - Weihede achieved a net profit of 65.97 million yuan in the first half of 2025, a year-on-year increase of 24.69% [66] - The company reported an operating income of 356 million yuan, up 38.37% year-on-year [66] - Basic earnings per share were 0.49 yuan [66] Group 41 - Huafa Co., Ltd. reported a net profit of 172 million yuan in the first half of 2025, a year-on-year decrease of 86.41% [67] - The company achieved an operating income of 38.199 billion yuan, up 53.46% year-on-year [67] - Basic earnings per share were 0.06 yuan [67] Group 42 - Mankun Technology achieved a net profit of 632 million yuan in the first half of 2025, a year-on-year increase of 62.30% [68] - The company reported an operating income of 760 million yuan, up 31.56% year-on-year [68] - Basic earnings per share were 0.43 yuan [68] Group 43 - Kelu Electronics achieved a net profit of 190 million yuan in the first half of 2025, turning from loss to profit [69] - The company reported an operating income of 2.573 billion yuan, up 34.66% year-on-year [69] - Basic earnings per share were 0.1144 yuan [69] Group 44 - Sanrenxing achieved a net profit of 144 million yuan in the first half of 2025, a year-on-year increase of 10.83% [71] - The company reported an operating income of 1.657 billion yuan, down 13.36% year-on-year [71] - Basic earnings per share were 0.68 yuan [71] Group 45 - Xinwei Communication achieved a net profit of 162 million yuan in the first half of 2025, a year-on-year decrease of 20.18% [72] - The company reported an operating income of 3.703 billion yuan, down 1.15% year-on-year [72] - Basic earnings per share were 0.1699 yuan [72] Group 46 - Yifan Pharmaceutical achieved a net profit of 304 million yuan in the first half of 2025, a year-on-year increase of 19.91% [72] - The company reported an operating income of 2.635 billion yuan, up 0.11% year-on-year [72] - Basic earnings per share were 0.25 yuan [72] Group 47 - *ST Chengchang achieved a net profit of 566 million yuan in the first half of 2025, turning from loss to profit [73] - The company reported an operating income of 201 million yuan, up 180.16% year-on-year [73] - Basic earnings per share were 0.2783 yuan [73] Group 48 - Rejing Bio announced that a controlling shareholder plans to reduce their stake by up to 1.08% [74] Group 49 - Jingu Co., Ltd. signed a strategic cooperation framework agreement with Luming Robotics [75]

证券代码：300813 证券简称：泰林生物 公告编号：2025-058 浙江泰林生物技术股份有限公司 关于全资子公司取得不动产权证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、对外投资概述 浙江泰林生物技术股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开第四届董事会第七次会议、第四届监事会第七次会议，于 2025 年 5 月 19 日召开 2024 年年度股东大会，审议通过了《关于 2021 年向不特定对象发行可转 换公司债券募集资金投资项目结项并将节余募集资金投入新项目及永久补充流 动资金的议案》《关于拟与杭州富春湾新城管理委员会签订高性能过滤器及配套 功 能 膜 产 业 化 项 目 合 同 书 的 议 案 》， 具 体 内 容 详 见 公 司 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露的《关于 2021 年向不特定对象发行可转换 公司债券募集资金投资项目结项并将节余募集资金投入新项目及永久补充流动 资金的公告》（公告编号：2025-030）、《关于拟与杭州富春湾新城管理委员会签 订 ...

Core Viewpoint - The article discusses the approval and details of the Guangdong Province Synthetic Biology Manufacturing Pilot Platform Project, highlighting its investment, construction scale, and the upcoming SynBioCon 2025 conference focused on synthetic biology and green manufacturing trends [3][4][5]. Project Approval and Details - The Guangdong Provincial Development and Reform Commission approved the preliminary design budget for the Synthetic Biology Manufacturing Pilot Platform Project, with a total investment of 21,733,000 yuan, including engineering costs of 19,459,000 yuan and other expenses [3]. - The project will establish four major pilot platforms: an intelligent microbial pilot platform, a functional macromolecule pilot platform, a green biomass methanol pilot platform, and an intelligent plant pilot platform, covering a construction area of approximately 8,500 square meters and acquiring about 365 sets of instruments and equipment [3][4]. SynBioCon 2025 Conference - The SynBioCon 2025 conference will be held from August 20 to 22 in Ningbo, Zhejiang, focusing on four main areas: AI in biological manufacturing, green chemical engineering and new materials, future food, and future agriculture [5]. - The conference aims to explore the development trends of the biological manufacturing industry during the 14th Five-Year Plan, innovations driven by AI, and the continuous vitality brought by new technologies and products [5]. - Various activities will take place during the conference, including a youth forum, high-level discussions, and a closed-door seminar on the "2025 Blue Book for AI Empowering Biological Manufacturing Industry Innovation" [5][11].

Core Insights - The report highlights the significant role of CFOs in listed companies, with the total compensation for CFOs in A-share companies reaching 4.27 billion yuan in 2024, averaging 814,800 yuan per year [1] - The average age of CFOs is approximately 47.95 years, with the majority aged between 40-49 years [3] - There is a notable disparity between CFO compensation and company performance, with several instances of high salaries despite poor financial results [7] Compensation Overview - The average salary for CFOs in the machinery and equipment-specialized equipment sector is about 655,600 yuan, with the highest salary being 3.20 million yuan and the lowest at 94,100 yuan [1] - The distribution of salaries shows that 49% of CFOs earn between 500,000 and 1 million yuan [1] Age and Education Distribution - The age distribution indicates that 45% of CFOs are between 40-49 years old, with the oldest being 65 years and the youngest at 33 years [3] - Educational qualifications reveal that there are 2 PhDs, 40 Master's degrees, 88 Bachelor's degrees, and 26 with lower qualifications, with corresponding average salaries of 2.11 million yuan, 741,100 yuan, 619,500 yuan, and 512,600 yuan respectively [5] Performance and Compliance Issues - There are discrepancies between CFO salaries and company performance, with examples of significant salary increases despite drastic declines in net profit [7] - A total of 14 CFOs received warnings or public notifications for compliance issues in 2024-2025 [7] - Specific cases include CFOs from companies like Sanyou Technology and Lingyun Light, who faced multiple warnings for various violations [8][9]

8月8日，泰林生物今日收盘24.67元，上涨4.22%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到279.29倍，总市值29.90亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均55.70倍，行业中值39.08倍，泰林生物排 名第118位。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13泰林生物279.29229.113.6329.90亿行业平均 55.7051.864.84117.31亿行业中值39.0838.492.8857.46亿1九安医疗11.1411.270.88188.05亿2英科医疗 15.5716.791.39246.03亿3山东药玻16.0616.111.85151.90亿4振德医疗16.3115.371.0459.21亿5新华医疗 16.4415.241.34105.38亿6奥美医疗17.0016.661.7561.43亿7九强生物17.7016.462.1787.65亿8维力医疗 18.1019.342.2842.44亿9奥泰生物18.4319.441.4958.79亿10康德莱18.7118.721.5540.32亿11鱼跃医疗 19.961 ...

8月7日，泰林生物今日收盘23.67元，下跌1.42%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到267.97倍，总市值28.69亿元。 股东方面，截至2025年3月31日，泰林生物股东户数11553户，较上次减少294户，户均持股市值35.28万 元，户均持股数量2.76万股。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均54.79倍，行业中值37.86倍，泰林生物排 名第118位。 最新一期业绩显示，2025年一季报，公司实现营业收入6693.90万元，同比-16.33%；净利润352.82万 元，同比-39.93%，销售毛利率49.27%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13泰林生物267.97219.823.4828.69亿行业平均 54.7951.294.80116.92亿行业中值37.8638.002.7755.22亿1九安医疗11.1511.280.88188.19亿2英科医疗 15.9217.161.42251.53亿3新华医疗16.1314.951.32103.38亿4振德医疗16.1915.261.0358.78亿5山东药玻 16.241 ...